SLC22A5 and neoplasm: Considering this, whether target lipopeptides bind OCTN2 to facilitate or impede carnitine transport, or whether they serve as OCTN2 substrates, will fundamentally determine the net biological consequence of this binding—tumor-suppressive or tumor-promoting.